Portman Square Capital LLP has filed its 13F form on October 16, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.47 Billion distributed in 107 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $6.12M, Wayfair Inc. with a value of $5.54M, Itron, Inc. with a value of $3.76M, Blackline, Inc. with a value of $3.52M, and Tetra Tech Inc with a value of $3.42M.

Examining the 13F form we can see an decrease of $1.01B in the current position value, from $2.48B to 1.47B.

Portman Square Capital LLP is based out at London, X0

Below you can find more details about Portman Square Capital LLP portfolio as well as his latest detailed transactions.

Portfolio value $1.47 Billion
Utilities: $307 Million
Technology: $298 Million
Industrials: $260 Million
Financial Services: $208 Million
ETFs: $176 Million
Consumer Cyclical: $44.2 Million
Real Estate: $42.4 Million
Energy: $36.5 Million
Other: $102 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 107
  • Current Value $1.47 Billion
  • Prior Value $2.48 Billion
  • Filing
  • Period Q3 2025
  • Filing Date October 16, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 11 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Portman Square Capital LLP Portfolio

Follow Portman Square Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Portman Square Capital LLP with notifications on news.